Company To Offer and Distribute Life Saving Product to the Home Builders Market
New York, New York and Henderson, Nevada (April 26, 2016): U.S. Home Builders Consultants, Inc. a leading supplier of innovative building products and technologies to the new construction/home improvement building markets and Rx Safes, Inc. (OTCQB: RXSF) a healthcare technology and medical device company that develops autonomous fingerprint security products, announced today that U.S. Home Builders Consultants has placed an order to purchase 5,000 Rx DrugSAFE units over a two year period commencing September 1, 2016.
Rx Safes designs and manufactures innovative and unique biometric security products in order to secure medications in the home and in professional environments from unauthorized access and diversion. The company management has over two decades of experience integrating biometric security into consumer products and is leading the charge against the drug abuse epidemic. The Rx DrugSAFE is a fingerprint secured medication lock box for the home and is designed to prevent unauthorized access to medication. U.S. Home Builders Consultants understands the needs of families when building or renovating their home, which typically install unsecure standard medicine cabinets that offer unrestricted access to prescription medication. U.S. Home Builders Consultants is leading the industry to prevent drug abuse with the addition of the Rx DrugSAFE to new projects.
“The Rx Safes product line continues to gain traction as the battle to prevent drug abuse continues,” commented Lorraine Yarde, Rx Safes’ Chief Executive Officer. “The order by U.S. Home Builders Consultants is the company’s first order under its newly created distributor program and confirms our position in the market as we look forward to forging additional relationships across different industries as we expand our sales and marketing efforts and reach.”
“As contractors for over 30 years, we believe that we are in a strong position to offer the Rx DrugSAFE as a value-add to contractors and have them incorporate the Rx DrugSAFE into new and existing home improvement construction projects,” stated Ms. Anna Krasovic, General Manager of U.S. Home Builders Consultants, Inc. “The Rx DrugSAFE is an inexpensive security device that allows our clients to send a strong message that the building and home improvement industries want to create a safe and secure environment for its customers”, Ms. Krasovic added.
U.S. Home Builders Consultants Inc. works with major home building, construction and home improvement industry associations, as well as national and local builders and property developers, from bathroom remodelers, to condominium developers. The company is developing an installation-training program for builders and a set of materials to provide customers outlining the dangers of drug abuse, as well as operating instruction on how to use the RxDrugSAFE once installed.
U.S. Home Builders Consultants will be introducing this product to all national and local building supply companies as well as national wholesale and home improvement retailers over the course of the next 12 months.
Contractors can begin ordering the Rx DrugSAFE exclusively through U.S. Home Builders Consultants, Inc. starting July 1, 2016. As the exclusive distributor of the Rx DrugSAFE product line for the homebuilding market, we offer special discounted bulk pricing within our industry. www.ushomebuilderconsultants.com
Please send all inquiries to USHBC.email@example.com
About Rx Safes, Inc.
Rx Safes, Inc. designs, develops, engineers, and markets fingerprint medical devices and security storage solutions for consumers and healthcare professionals to regulate and secure the use of controlled substances at the end user (patient and consumer) level using patented, autonomous fingerprint technology that offers greater security and tighter controls over controlled substances. The company’s innovative and unique biometric security products include biometric PCA infusion pump regulators (RxSafeDOSE), biometric needleless injectors (Rx MyDOSE) and a line of biometric security and storage products (Rx DrugSAFE product line) designed for hospitals, Emergency Service providers, professional healthcare workers, assisted living facilities, skilled nursing facilities, out-patient clinic, private physician offices, as well as consumers. It is estimated that more than 100 people die each day in the U.S. from misuse and unauthorized access to controlled substances with a social and economic price tag of over $600 billion. The Company is dedicated to providing comprehensive solutions to address the economic issues caused by drug diversion and unauthorized access to these medications, with products ranging from fingerprint medication safes, portable medical storage solutions, PCA pendants, Needle Free Injectors, locks and its revolutionary Rx SafeEHR product which is a portable HIPAA compliant electronic health record. The company works with OEM’s to improve their legacy products by integrating its patented autonomous fingerprint technology, while innovating and producing its own products. For additional information please visit www.rxdrugsafe.com.
About U.S. Home Builders Consultants Inc.
U.S. Home Builders Consultants has been in the building contract business since 1985, starting out as a home improvement construction company that has transformed into one of the best boutique home and commercial construction consulting firms in the country. The company directly assisted in projects ranging from $1500 bathroom renovations, to multi-million dollar multi-unit condominium construction. The company uniquely uses technology in all aspects of the projects it consults on, and has used technology to improve construction management time lines, reduce product and building supply costs, as well as provide state of the art upgrades in all projects we consult on. With annual revenues exceeding $5M, U.S. Home Builders Consultants are always looking to improve the quality of the building process from projects to products to improve homeowners’ lives.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the Securities and Exchange Commission.
Investor Relations Contact:
Like us on Facebook at https://www.facebook.com/rxsafes
Follow us on Twitter at https://twitter.com/RxDrugSAFE